Kari L. Kendra, MD, PhD

Professor, Division of Medical Oncology, Department of Medicine
Ohio State University James Cancer Hospital, Columbus, OH, USA, United States

Presentation(s):

• 57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations

  Friday, March 24, 2023
  10:24 AM – 10:34 AM

  Disclosure information not submitted.